Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$52,579,925
+$23,758,586 QoQ
Shares Held
208,949
+57.7% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
3.12%
of 13F equity value
Holder Rank
#351
of 4,153 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kepler Cheuvreux (Suisse) SA holds $171,687,299 across 8 Drug Manufacturers - General names. ABBV ranks #1 (30.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
208,949 | $52,579,925 | |
| 2 | PFE |
Pfizer Inc
|
1,405,592 | $33,846,655 | |
| 3 | MRK |
Merck & Co., Inc.
|
202,568 | $26,029,987 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
198,637 | $25,095,798 | |
| 5 | JNJ |
Johnson & Johnson
|
85,510 | $21,716,973 | |
| 6 | AMGN |
Amgen Inc
|
25,387 | $9,193,140 | |
| 7 | LLY |
ELI LILLY & Co
|
2,644 | $3,171,293 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
929 | $53,528 |
All Filings in ABBV
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,579,925 | 208,949 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $28,821,339 | 132,518 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $31,352,026 | 137,214 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $7,539,637 | 32,563 | Shares | Defined | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||